Axon Enterprise vs Smith & Wesson Brands
AXON and SWBI side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AXON and SWBI compare
Axon Enterprise is the larger company, worth 34 times as much as Smith & Wesson Brands ($24.3B against $713M).
Axon Enterprise grew revenue faster over the last twelve months (33.6% versus 17.0% for Smith & Wesson Brands).
Axon Enterprise keeps more of each dollar of sales as profit, with a net margin of 7.6% compared with 4.4% at Smith & Wesson Brands.
Smith & Wesson Brands pays a dividend yielding 3.3%; Axon Enterprise does not pay one.
Smith & Wesson Brands scores higher on the StockData Score (13 against 7 for Axon Enterprise), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AXON | SWBI |
|---|---|---|
| Size and price | ||
| Market cap | $24.3B | $713M |
| Share price | $298.59 | $15.91 |
| Change, 1 year | −46.1% | 86.3% |
| Change, 5 years | 68.5% | −29.1% |
| Beta (5Y) | 1.49 | −0.15 |
| Employees | 5,100 | 46 |
| StockData Score | ||
| Total score | 7 | 13 (better) |
| Valuation score | 1 | 1 |
| Growth score | 3 | 3 |
| Performance score | 1 (better) | 0 |
| Health score | 2 | 6 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 95.7× | – |
| P/S | 7.1× | 1.3× (better) |
| P/B | 6.4× | 1.9× (better) |
| EV/EBITDA | 133× | 10.4× (better) |
| P/FCF | 300× | 8.7× (better) |
| FCF yield | 0.33% | 11.5% (better) |
| Fair value | $100.83 | $14.88 |
| Margin of safety | −196% | −6.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 33.6% (better) | 17.0% |
| Revenue growth, 5Y average | 32.5% (better) | −13.1% |
| Net income growth (TTM) | 0.54% | 106% (better) |
| EPS growth (TTM) | −0.95% | – |
| EPS growth, 5Y average | – | −38.2% |
| Profitability | ||
| Gross margin | 58.5% (better) | 27.4% |
| Operating margin | 2.0% | 6.6% (better) |
| Net margin | 7.6% (better) | 4.4% |
| FCF margin | 2.4% | 14.9% (better) |
| Return on equity | 7.6% (better) | 6.6% |
| Return on invested capital | 1.8% | 7.7% (better) |
| Financial health | ||
| Debt / equity | 0.76 (better) | 0.00 |
| Net debt / EBITDA | 6.35 | – |
| Interest coverage | 0.6× | – |
| Current ratio | 3.00 | 3.62 (better) |
| Altman Z-score | 3.86 | 5.55 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 3.3% |
| Payout ratio | – | 95.3% |
| Years of dividend growth | – | 0 |
| Shareholder yield | 0.00% | 3.3% (better) |
| Ownership | ||
| Held by institutions | 89.1% | 64.8% |
| Held by insiders | 5.4% | 23.4% |
| Insider net buying, 12 months | −$122M | – |
| Short interest, % of float | 5.3% | 5.0% |
Go deeper
- AXON stock overview
- AXON income statement
- AXON valuation and score
- SWBI stock overview
- SWBI income statement
- SWBI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.